Physician profile
Puja Sharma
NPI 1548518350
$1,799.26
in general payments reported to CMS, 2019-2025
14 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.97 · 2023: $428 · 2024: $904 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,713.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $504.81 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $297.70 | 2022-2024 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $193.52 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $189.28 | 2023-2025 | Rexulti |
| Abbvie INC. | $173.13 | 2023-2025 | Qulipta |
| Lilly USA, LLC | $131.19 | 2024-2025 | Zepbound, Mounjaro |
| Lundbeck LLC | $120.76 | 2022-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $43.38 | 2024-2025 | Voquezna |
| Abbott Laboratories | $37.03 | 2024 | Assurity |
| Pfizer INC. | $36.51 | 2024 | |
| Exact Sciences Corporation | $25.61 | 2024 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $17.01 | 2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $15.51 | 2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.